Publications by authors named "Atakan Demir"

Claim this Profile
L
Long-Term Oncological Outcomes for Locally Advanced Rectal Cancer Patients with Pathological Complete Response After Neoadjuvant Chemoradiotherapy: A Turkish Oncology Group Study.
Mukremin Uysal, Sezer Saglam, İsmail Beypınar, Esra Kaytan Saglam, Elkhan Mammadov, Atike Gokcen Demiray, Atakan Demir

Cancer Invest· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Talazoparib in patients with BRCA mutant metastatic breast or ovarian carcinoma: results of early access program.
Mehmet Ali Nahit Sendur, Mutlu Hizal, Burcu Çakar, Oktay Halit Aktepe, Emrah Eraslan, Necla Demir, Nuriye Özdemir, Umut Demirci, Atakan Demir

BMC Cancer· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Beyond traditional therapies: clinical significance of complex molecular profiling in patients with advanced solid tumours-results from a Turkish multi-centre study.
Omer Fatih Olmez, Ahmet Bilici, Ozlem Er, Atil Bisgin, Alper Sevinc, Atakan Demir

Jpn J Clin Oncol· May 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The effectiveness and safety of neoadjuvant pertuzumab and trastuzumab in women with locally advanced, inflammatory, or early-stage human epidermal growth factor receptor 2-positive breast cancer: Turkish Oncology Group study.
Özlem Özdemir, Baha Zengel, Yaşar Yildiz, Basak Oyan Uluç, Devrim Cabuk, Atakan Demir, Hacer Demir

Anticancer Drugs· August 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Identifying Knowledge and Practices regarding Cancer Patient Malnutrition: A Survey Study among Oncologists.
Ozlem Sonmez, Evrim Tezcanli, Dilsat Bas, Hande Busra Kazanci, Ayse Altinok, Atakan Demir

Nutr Cancer· July 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Trastuzumab ± Capecitabine Maintenance After the First-Line Treatment of HER2-Positive Advanced Gastric Cancer: Retrospective Observational Real-Life Data of Turkish Oncology Group.
Mustafa Gürbüz, Erman Akkuş, Abdullah Sakin, Semiha Urvay, Atike Gökçen Demiray, Atakan Demir

J Gastrointest Cancer· June 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Real-Life Analysis of Efficacy and Safety of Everolimus Plus Exemestane in Hormone Receptor-Positive, Human Epidermal Growth Factor Receptor-2-Negative Metastatic Breast Cancer Patients: A Turkish Oncology Group (TOG) Study.
Ahmet Bilici, Mukremin Uysal, Serkan Menekse, Semih Akin, Fatih Yildiz, Atakan Demir

Cancer Invest· February 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Combination of trastuzumab and taxane-containing intensified chemotherapy in first-line treatment of HER2-positive advanced gastric cancer.
Mustafa Gürbüz, Erman Akkuş, Abdullah Sakin, Semiha Urvay, Atike Gökçen Demiray, Atakan Demir

Tumori· October 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Real-life comparison of the afatinib and first-generation tyrosine kinase inhibitors in nonsmall cell lung cancer harboring EGFR exon 19 deletion: a Turk Oncology Group (TOG) study.
Burak Bilgin, Mehmet Ali Nahit Sendur, Sebnem Yucel, Emir Celik, Deniz Tataroglu Ozyukseler, Atakan Demir, Ahmet Demirkazık

J Cancer Res Clin Oncol· July 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy and Safety of Trastuzumab Emtansine in Her2 Positive Metastatic Breast Cancer: Real-World Experience.
Aykut Bahçeci, Semra Paydaş, Naziye Ak, Ferhat Ferhatoğlu, Pınar Mualla Saip, Atike Gökçen Demiray, Fuat Hulusi Demirelli, Hacer Demir, Atakan Demir

Cancer Invest· July 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Early PSA response to antiandrogen therapy in metastatic castration-resistant prostate carcinoma patients: A predictive marker for progression-free survival?
Demir Atakan, Alan Ozkan, Mert Aslihan Guve, Koca Sinan

J BUON· February 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
W
Worse patient-physician relationship is associated with more fear of cancer recurrence (Deimos Study): A study of the Palliative Care Working Committee of the Turkish Oncology Group (TOG).
Ali Alkan, Arzu Yaşar, Zeynep Gülsüm Güç, Mustafa Gürbüz, Tuğba Başoğlu, Özlem Özdemir, Atike Gökçen Demiray, Atakan Demir

Eur J Cancer Care (Engl)· November 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Corrigendum to "The impact of total neo-adjuvant treatment on nonoperative management in patients with locally advanced rectal cancer: The evaluation of 66 cases in a single center" [Eur. J. Surg. Oncol. 46/3 (2019) 402-409].
Oktar Asoglu, Handan Tokmak, Baris Bakir, Gokhan Demir, Enis Ozyar, Atakan Demir

Eur J Surg Oncol· September 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The impact of total neo-adjuvant treatment on nonoperative management in patients with locally advanced rectal cancer: The evaluation of 66 cases.
Oktar Asoglu, Handan Tokmak, Baris Bakir, Gokhan Demir, Enis Ozyar, Atakan Demir

Eur J Surg Oncol· March 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy of Palbociclib and Endocrine Treatment in Heavily Pretreated Hormone Receptor-positive/HER2-negative Advanced Breast Cancer: Retrospective Multicenter Trial.
Atakan Demir, Nil Molinas Mandel, Semra Paydas, Gökhan Demir, Özlem Er, Hacer Demir

Balkan Med J· February 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Tumor budding for predicting prognosis of resected rectum cancer after neoadjuvant treatment.
Atakan Demir, Ozkan Alan, Ertugrul Oruc

World J Surg Oncol· March 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Immunohistochemical HER2 Status Evaluation in Breast Cancer Pathology Samples: A Multicenter, Parallel-Design Concordance Study.
Tülay Canda, Ekrem Yavuz, Necmettin Özdemir, Sennur İlvan, Serpil Sak Dizbay, Atakan Demir

Eur J Breast Health· July 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
BRCA mutations in women with inflammatory breast cancer.
Angelica M Gutierrez Barrera, Tamer M Fouad, Juhee Song, Rachel Webster, Nisreen Elsayegh, Atakan Demir

Cancer· February 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Attitudes of cancer patients after diagnosis: How cancer affects social life? A Turkish Oncology Group study.
Erdinc Nayir, Mahmut Bakir Koyuncu, Ece Esin, Ibrahim Turker, Ozgur Tanriverdi, Atakan Demir

J BUON· August 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis